Key result
A 20 ms increase in baseline QRS duration predicted a 30-40% relative increase in 30-day mortality in patients with anterior AMI.
Why the study?
Does baseline QRS duration predict 30-day mortality in patients with different locations of ST elevation myocardial infarction?
RCT (n=12,966)
randomized
Does baseline QRS duration predict 30-day mortality in patients with different locations of ST elevation myocardial infarction?
Baseline QRS duration is an independent predictor of 30-day mortality in patients with anterior STEMI, but not inferior STEMI, regardless of the presence of right bundle branch block.
Answers are grounded in this paper and cite their sources.
Supports QRS duration for risk stratification in anterior STEMI; leaves open prospective validation and broader applicability.
OBJECTIVE: To discern if the prognostic meaning of QRS prolongation differs according to the location of ST elevation acute myocardial infarction DESIGN: Measuring QRS duration in patients with normal conduction or right bundle branch block SETTING: HERO-2 trial with prospective collection of electrocardiograms at randomisation and at 60 min after fibrinolytic therapy PATIENTS: 12 456 patients with normal conduction at both randomisation and 60-min time points and 510 with right bundle branch block (RBBB) at both time points MAIN OUTCOME MEASURE: 30-day mortality. RESULTS: On the baseline ECG, there was a positive association between QRS duration and 30-day mortality with anterior acute myocardial infarction (AMI) (p<0.0001 for those with normal conduction and = 0.007 for those with RBBB) but not with inferior AMI (p = 0.29 and p = 0.32, respectively). For anterior AMI, with or without RBBB, an increment of 20 ms increase in QRS duration predicted a significant 30-40% relative increase in 30-day mortality both before and after adjusting for clinical and ECG variables including baseline ST elevation and presence of Q waves. The association was not present for inferior AMI. Changes in QRS duration over 60 min after fibrinolytic therapy were uncommon and unrelated to mortality. CONCLUSION: Baseline QRS duration independently stratifies 30-day mortality in patients with anterior AMI, even when unaccompanied by RBBB, but does not stratify mortality risk in patients with inferior AMI.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2008) conducted an RCT in ST elevation acute myocardial infarction (n=12,966). QRS duration was evaluated on 30-day mortality (30-40% relative increase, p=<0.0001). A 20 ms increase in baseline QRS duration predicted a 30-40% relative increase in 30-day mortality in patients with anterior AMI.
Synapse has enriched 10 related papers. Consider them for comparative context: